Showing 581-590 of 856 results for "".
- New Breast Implant Is MDR-Approvedhttps://modernaesthetics.com/news/new-breast-implant-is-mdr-approved/2473566/The new European Medical Device Regulation (MDR) has approved a breast implant for the first time, according to a press release from GC Aesthetics® (GCA®). Under the new MDR rules set forth by the European Union (EU), medical standards are updated rigorousl
- FDA Issues Alert for Counterfeit Botox Across Multiple U.S. Stateshttps://modernaesthetics.com/news/fda-issues-alert-for-counterfeit-botox-across-multiple-us-states/2473560/The U.S. Food and Drug Administration (FDA) has issued an alert regarding counterfeit botulinum toxin that has been detected in several states. The agency issued a statement on April 16 noting that it is aware of the issue and is working with the Centers for Disease Control (CDC),
- Botulism-Like Symptoms Linked to Suspected Fake Cosmetic Injections in Illinoishttps://modernaesthetics.com/news/botulism-like-symptoms-linked-to-suspected-fake-cosmetic-injections-in-illinois/2473557/The Illinois Department of Public Health (IDPH) has issued a warning to healthcare facilities, particularly hospital ERs, urging heightened vigilance for patients exhibiting symptoms resembling botulism. The advisory follows the identification of a clus
- Allergan Aesthetics Launches Program to Elevate the Conversation Around Ethics in Aestheticshttps://modernaesthetics.com/news/allergan-aesthetics-launches-program-to-elevate-the-conversation-around-ethics-in-aesthetics/2473556/Allergan Aesthetics announced the launch of 'Moving the Needle on Ethics,' a collaboration with medical aesthetics experts from around the globe aimed at elevating discussions on ethics in aesthetics. The collection of interviews is designed to highlight the
- FDA Approves Juvederm Voluma XC for Temple Hollowinghttps://modernaesthetics.com/news/fda-approves-juvederm-voluma-xc-for-temple-hollowing/2473553/Allergan Aesthetics has received FDA approval of Juvederm Voluma XC for injection in the temple region to improve moderate to severe temple hollowing in adults over the age of 21.[1] The injection is the first and only hyaluronic acid (HA) dermal filler to receive FDA approval
- Kenvue to Showcase 22 New Sets of Clinical Data at AADhttps://modernaesthetics.com/news/kenvue-to-showcase-22-new-sets-of-clinical-data-at-aad/2473552/Kenvue announced it will share 22 data sets detailing new Kenvue skin science research at the American Academy of Dermatology (AAD) Association annual meeting, March 8-12, in San Diego. Evidence will be presented on the clinical effectiveness of Neutrogena and Aveeno
- Trufacial Touts Survey Showing High Satisfaction with Facial Rejuvenation Systemhttps://modernaesthetics.com/news/trufacial-survery-results/2473550/A market survey of 100 female consumers revealed that 100% of participants found the skin-perfecting TrufacialTM hand-held device not only met their skincare needs, but also exceeded expectations after only
- Cutera Launches AviClear for the Treatment of Acne in UK, Europe and Australiahttps://modernaesthetics.com/news/cutera-launches-aviclear-for-the-treatment-of-acne-in-uk-europe-and-australia/2473548/Cutera announced the international limited commercial release of AviClear, which the company describes as the first energy-based device FDA-cleared for the long-term treatment of mild, moderate, and severe acne. AviClear is now commercially available, on a limited basis, in the UK, Europe, a
- Beauty and Self-Care Brands Announce Rennaï Spotshttps://modernaesthetics.com/news/beauty-and-self-care-brands-announce-rennai-spots/2473546/Rennaï, a new beauty and self-care retail concept in Montreal, announced that luxury global brand Hermes will be joining world-renowned professional-grade skin care brand Dermalogica at its flagship location at Royalmount. The combination of coveted luxury brands, ma
- Tracking Trends in Breast Implant Surgery Techniques From 2005 to 2020https://modernaesthetics.com/news/tracking-trends-in-breast-implant-surgery-techniques-from-2005-to-2020/2473538/Breast implant placement with inframammary incisions increased from 68% to 80%, while use of peri-areolar incisions decreased from 24% to 14% between 2005 and 2020, according to a study in the December 2023 issue of Plastic and Reconstruct